720 Enhancing the anti-tumor immunity and therapeutic potential of ICT01, a butyrophilin3A-targeted, γ9δ2 T cell-activating monoclonal antibody, with low dose IL-2 in patients with advanced solid tumors: The EVICTION-2 trial
Regular and Young Investigator Award Abstracts（2022）
关键词
monoclonal antibody,advanced solid tumors,immunity,ict01,anti-tumor,a-targeted,cell-activating
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要